From the Department of Neurosurgery, Mayo Clinic, Rochester, MN. (L.R., H.C., L.R.C., W.B.).
Department of Neurology, Mayo Clinic, Rochester, MN. (A.A.R.).
Stroke. 2019 Sep;50(9):2428-2432. doi: 10.1161/STROKEAHA.118.024651. Epub 2019 Aug 1.
Background and Purpose- Racial and ethnic disparities in the access to mechanical thrombectomy (MT) for treatment of acute ischemic stroke (AIS) secondary to large vessel occlusion have been previously described. The effect of recent randomized trials validating MT as an effective therapy for AIS secondary to large vessel occlusion on such disparities has not been investigated. Methods- Information on admissions for AIS to endovascular centers occurring between January 2016 and September 2018 was obtained from a national database. The number of patients receiving IV-tPA (intravenous tissue-type plasminogen activator) and MT at each institution was determined, and patient demographics were characterized according to age, sex, race/ethnicity, and insurance status. Comparisons of patients who did and did not undergo MT and between patients of different racial and ethnic backgrounds were performed. Demographic variables independently associated with the utilization of MT were identified using multivariate linear regression analysis. Results- There were 206 853 admissions to 173 endovascular centers during the time period of interest. The overall utilization of MT was 8.4%. The utilization of MT for black/Hispanic patients was lower than that among white/non-Hispanic patients (7.0% versus 9.8%; P<0.001). Black/Hispanic patients were also less likely to receive IV-tPA (16.2% versus 20.5%; P<0.001) and to be admitted to the endovascular center after transfer from a different hospital (20.0% versus 30.1%; P<0.001). On multivariate linear regression analysis, increasing institutional proportions of patients with female sex (β=-0.601; P<0.001), insurance with Medicaid or uninsured status (β=-0.153; P=0.029), and black/Hispanic race/ethnicity (β=-0.062; P=0.046) were independently associated with lower institutional utilization of MT. Conclusions- Despite the mainstream acceptance of MT for the treatment of AIS secondary to large vessel occlusion, racial and ethnic disparities in the utilization of MT persist.
背景与目的- 先前已有研究描述了在接受机械取栓(MT)治疗大动脉闭塞性急性缺血性脑卒中(AIS)方面存在的种族和民族差异。最近的随机试验验证了 MT 作为大动脉闭塞性 AIS 的有效治疗方法,但其对这些差异的影响尚未得到调查。方法- 从一个国家数据库中获取了 2016 年 1 月至 2018 年 9 月期间发生在血管内治疗中心的 AIS 入院信息。确定了每个机构接受 IV-tPA(静脉内组织型纤溶酶原激活剂)和 MT 的患者数量,并根据年龄、性别、种族/民族和保险状况对患者的人口统计学特征进行了描述。比较了接受和未接受 MT 的患者以及不同种族和民族背景的患者。使用多元线性回归分析确定与 MT 使用相关的人口统计学变量。结果- 在研究期间,共有 206853 名患者入组 173 个血管内治疗中心。MT 的总体使用率为 8.4%。黑人和西班牙裔患者使用 MT 的比例低于白人和非西班牙裔患者(7.0%比 9.8%;P<0.001)。黑人和西班牙裔患者接受 IV-tPA 的可能性也较低(16.2%比 20.5%;P<0.001),而且从其他医院转院到血管内治疗中心的可能性也较低(20.0%比 30.1%;P<0.001)。多元线性回归分析显示,机构中女性患者比例增加(β=-0.601;P<0.001)、保险为医疗补助或无保险状态(β=-0.153;P=0.029)和黑人和西班牙裔种族/民族(β=-0.062;P=0.046)与 MT 的机构使用率降低独立相关。结论- 尽管 MT 已被主流接受用于治疗大动脉闭塞性 AIS,但在 MT 的使用方面仍存在种族和民族差异。